Dicerna Pharma (DRNA) Reports In-Line Q4 EPS

Dicerna Pharma (NASDAQ: DRNA) reported Q4 EPS of ($0.57), in-line with the analyst estimate of ($0.57).

For earnings history and earnings-related data on Dicerna Pharma (DRNA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M